What Are They?

Human iPSCs have the unique capability to replicate indefinitely and give rise to all cell types of the human body, including the cell types required for repair.

Since Japanese researcher Dr. Shinya Yamanaka’s Nobel Prize-winning discovery of iPSCs in 2006, they have become a major platform for new regenerative medicine therapies.

How They’re Being Put to Use

Scientists and clinicians are actively developing human iPSC-based treatments for numerous conditions including: